BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10630375)

  • 1. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin.
    Shin SH; Kim JC; Chang SI; Lee H; Chung SI
    Cornea; 2000 Mar; 19(2):212-7. PubMed ID: 10746455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
    Jimi S; Ito K; Kohno K; Ono M; Kuwano M; Itagaki Y; Ishikawa H
    Biochem Biophys Res Commun; 1995 Jun; 211(2):476-83. PubMed ID: 7540839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea.
    Phillips GD; Stone AM; Jones BD; Schultz JC; Whitehead RA; Knighton DR
    In Vivo; 1994; 8(6):961-5. PubMed ID: 7539637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of corneal neovascularization by rapamycin.
    Kwon YS; Kim JC
    Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3.
    Joe YA; Hong YK; Chung DS; Yang YJ; Kang JK; Lee YS; Chang SI; You WK; Lee H; Chung SI
    Int J Cancer; 1999 Aug; 82(5):694-9. PubMed ID: 10417767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
    Edelman JL; Castro MR; Wen Y
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM.
    Youn MR; Park MH; Choi CK; Ahn BC; Kim HY; Kang SS; Hong YK; Joe YA; Kim JS; You WK; Lee HS; Chung SI; Chang SI
    Biochem Biophys Res Commun; 2006 May; 343(3):917-23. PubMed ID: 16564503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
    Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
    Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.
    Cao R; Bråkenhielm E; Li X; Pietras K; Widenfalk J; Ostman A; Eriksson U; Cao Y
    FASEB J; 2002 Oct; 16(12):1575-83. PubMed ID: 12374780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
    Knighton DR; Phillips GD; Fiegel VD
    J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.